Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Envelope Marker (Ab133741)

推荐稀释比例

• IHC-P1/300 Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
• WB1/1000 - 1/10000
• ICC/IF1 µg/mL Recommended for methanol-fixed samples in ICC only. Use ab229025 for compatibility with both methanol and PFA.
• IP1/20

Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Envelope Marker (ab133741) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ICC/IF, IHC-P, IP, WB in human, mouse, rat samples. Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Envelope Marker (ab133741) has been cited over 189 times in peer reviewed journals and is trusted by the scientific community. Abcams high quality manufacturing and validation processes ensure Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Envelope Marker (ab133741) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Envelope Marker (ab133741) has been confirmed by testing in knockout samples. Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Envelope Marker (ab133741) has 14 independent reviews from customers. Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Envelope Marker (ab133741) specifically detects Lamin B1 (UniProt ID: P20700; Molecular weight: 66kDa) and is sold in a convenient trial size to enable initial testing (20 uL) and larger sizes for subsequent scaling up experiments (100 uL and 1 mL). Conjugation-ready, carrier free format available for antibody clone EPR8985(B) - ab22797. Antibody clone EPR8985(B) is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 488, Alexa Fluor ® 647, HRP, Alexa Fluor ® 594 ( ab19416, ab19418, ab19419, ab216723 ). Lamin B1/LMNB1/LMNB is a critical component of the nuclear lamina, playing a vital role in chromatin organization and nuclear stability. Utilizing our lmnb1 antibody can significantly enhance the detection and study of Lamin B1. Research indicates that mutations in Lamin B1 are linked to demyelinating diseases, such as adult-onset autosomal dominant leukodystrophy (ADLD), highlighting its importance in maintaining neural health Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.